Infarction, Middle Cerebral Artery
15
1
1
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
1 terminated out of 15 trials
90.0%
+3.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (15)
Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients
Testing of Identification Markers for Stroke
Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in Vietnam
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial
A Comparison Between Two Techniques for Performing Decompressive Craniectomy
Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
Impact of Cranioplasty On Cerebral Perfusion
Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
Implantation of Olfactory Ensheathing Cells (OECs)
Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke
Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke